You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 275 No. 3, January 17, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communications
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Malaria, the Submerged Disease

Piero Olliaro, MD, PhD; Jacqueline Cattani, PhD, MPH; Dyann Wirth, PhD

JAMA. 1996;275(3):230-233.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MALARIA is one of the major infectious diseases in the world today despite years of efforts first to eradicate it and subsequently to reduce its impact on mortality and morbidity. Plasmodium falciparum, the most virulent of the four human Plasmodium species causing malaria, is potentially life-threatening, increasing in prevalence and becoming even more resistant to in-use drugs.

The World Health Organization (WHO) estimates that there are 300 million to 500 million people infected with malaria.1 The Global Burden of Disease study, used as an input into the World Bank's 1993 World Development Report,2 estimated 805 300 deaths due to malaria in sub-Saharan Africa in 1990, compared with 887100 for diarrheal disease, 1 028 800 for all respiratory infections, and 472 000 for measles.3 The true impact of malaria on mortality is likely to be underestimated in these figures, since a randomized trial of the use of insecticide-impregnated . . . [Full Text PDF of this Article]


Author Affiliations

From the UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland (Drs Olliaro and Cattani), and the Department of Tropical Public Health, Harvard School of Public Health, Boston, Mass (Dr Wirth).


Footnotes

Reprint requests to Steering Committee on Drugs for Malaria (CHEMAL), UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, 20 ave Appia, 1211 Geneva 27, Switzerland (Dr Olliaro).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.